Holdings of SEB Läkemedelsfond
SEB Funds AB · Original filing · Compare with another fund · Report an error
- Net assets
- 16.2B SEK including 15.9B SEK in equities, 98.6 %
- Positions
- 65 in 11 countries
- Top ten
- 45.4 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 158,794 | 1.4B SEK | 8.61 % |
| 2 | Merck & Co Inc | 1,077,226 | 1.2B SEK | 7.64 % |
| 3 | AstraZeneca PLC | 629,429 | 1.2B SEK | 7.18 % |
| 4 | Johnson & Johnson | 355,035 | 826.7M SEK | 5.11 % |
| 5 | Thermo Fisher Scientific Inc | 112,809 | 528.2M SEK | 3.27 % |
| 6 | Gilead Sciences Inc | 370,354 | 491.7M SEK | 3.04 % |
| 7 | Teva Pharmaceutical Industries Ltd | 1,710,688 | 490.8M SEK | 3.04 % |
| 8 | Stryker Corp | 132,057 | 413.4M SEK | 2.56 % |
| 9 | UCB SA | 145,378 | 412.5M SEK | 2.55 % |
| 10 | Novo Nordisk A/S | 1,162,127 | 394.2M SEK | 2.44 % |
| 11 | Boston Scientific Corp | 644,375 | 385.2M SEK | 2.38 % |
| 12 | Vertex Pharmaceuticals Inc | 86,236 | 366.8M SEK | 2.27 % |
| 13 | HCA Healthcare Inc | 77,199 | 348M SEK | 2.15 % |
| 14 | McKesson Corp | 41,539 | 342.4M SEK | 2.12 % |
| 15 | CVS Health Corp | 465,952 | 318.8M SEK | 1.97 % |
| 16 | Chugai Pharmaceutical Co Ltd | 560,200 | 288.9M SEK | 1.79 % |
| 17 | IQVIA Holdings Inc | 177,092 | 287.7M SEK | 1.78 % |
| 18 | UnitedHealth Group Inc | 108,792 | 280.4M SEK | 1.73 % |
| 19 | Roche Holding AG | 73,020 | 272.4M SEK | 1.69 % |
| 20 | Intuitive Surgical Inc | 61,492 | 270M SEK | 1.67 % |
| 21 | Edwards Lifesciences Corp | 340,460 | 259.7M SEK | 1.61 % |
| 22 | Cencora Inc | 85,611 | 256.2M SEK | 1.58 % |
| 23 | Protagonist Therapeutics Inc | 232,416 | 233.4M SEK | 1.44 % |
| 24 | Lonza Group AG | 36,044 | 215.7M SEK | 1.33 % |
| 25 | Quest Diagnostics Inc | 114,356 | 213.5M SEK | 1.32 % |
| 26 | STERIS PLC | 98,270 | 207M SEK | 1.28 % |
| 27 | GSK PLC | 764,745 | 198.3M SEK | 1.23 % |
| 28 | Insmed Inc | 119,825 | 186.7M SEK | 1.15 % |
| 29 | Dexcom Inc | 299,986 | 179.5M SEK | 1.11 % |
| 30 | ImmunityBio Inc | 2,447,150 | 178.8M SEK | 1.11 % |
| 31 | Daiichi Sankyo Co Ltd | 1,060,100 | 175.6M SEK | 1.09 % |
| 32 | Bridgebio Pharma Inc | 235,813 | 166.8M SEK | 1.03 % |
| 33 | Eurofins Scientific SE | 234,559 | 161.3M SEK | 1.00 % |
| 34 | Cooper Cos Inc/The | 234,811 | 159.9M SEK | 0.99 % |
| 35 | BEONE MEDICINES LTD | 56,078 | 158.6M SEK | 0.98 % |
| 36 | Genmab A/S | 59,712 | 150.2M SEK | 0.93 % |
| 37 | Insulet Corp | 73,867 | 147.7M SEK | 0.91 % |
| 38 | BioNTech SE | 170,060 | 144M SEK | 0.89 % |
| 39 | Argenx SE | 20,804 | 141.8M SEK | 0.88 % |
| 40 | BrightSpring Health Services Inc | 341,465 | 138.6M SEK | 0.86 % |
| 41 | Sectra AB | 556,514 | 125.9M SEK | 0.78 % |
| 42 | Krystal Biotech Inc | 46,343 | 114M SEK | 0.71 % |
| 43 | Structure Therapeutics Inc | 245,043 | 112.5M SEK | 0.70 % |
| 44 | Natera Inc | 57,672 | 109.9M SEK | 0.68 % |
| 45 | BoneSupport Holding AB | 533,203 | 103.9M SEK | 0.64 % |
| 46 | BioArctic AB | 323,312 | 103.5M SEK | 0.64 % |
| 47 | Arrowhead Pharmaceuticals Inc | 158,205 | 94.5M SEK | 0.58 % |
| 48 | Ascendis Pharma A/S | 38,665 | 84.2M SEK | 0.52 % |
| 49 | Newamsterdam Pharma Co NV | 272,654 | 83.1M SEK | 0.51 % |
| 50 | Ionis Pharmaceuticals Inc | 114,334 | 81.8M SEK | 0.51 % |
| 51 | Upstream Bio Inc | 878,473 | 75.3M SEK | 0.47 % |
| 52 | Crinetics Pharmaceuticals Inc | 213,891 | 74M SEK | 0.46 % |
| 53 | KalVista Pharmaceuticals Inc | 351,305 | 67.4M SEK | 0.42 % |
| 54 | Edgewise Therapeutics Inc | 206,512 | 62M SEK | 0.38 % |
| 55 | Molina Healthcare Inc | 48,068 | 61M SEK | 0.38 % |
| 56 | Cogent Biosciences Inc | 164,437 | 60.3M SEK | 0.37 % |
| 57 | Soleno Therapeutics Inc | 187,475 | 59.8M SEK | 0.37 % |
| 58 | Oxford Nanopore Technologies PLC | 3,583,057 | 49.9M SEK | 0.31 % |
| 59 | Olema Pharmaceuticals Inc | 339,461 | 48.2M SEK | 0.30 % |
| 60 | RadNet Inc | 76,697 | 40.8M SEK | 0.25 % |
| 61 | Revolution Medicines Inc | 36,214 | 33.5M SEK | 0.21 % |
| 62 | Corvus Pharmaceuticals Inc | 226,837 | 31.6M SEK | 0.20 % |
| 63 | ZENAS BIOPHARMA INC | 163,860 | 30.5M SEK | 0.19 % |
| 64 | Viridian Therapeutics Inc | 156,957 | 29.2M SEK | 0.18 % |
| 65 | Onward Medical NV | 496,621 | 18.1M SEK | 0.11 % |
Sector breakdown
- Health care 71.3 %
- Unattributed 28.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- SEK 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 70.0 %
- United Kingdom 8.8 %
- Denmark 3.9 %
- Belgium 3.5 %
- Israel 3.1 %
- Switzerland 3.1 %
- Japan 2.9 %
- Sweden 2.1 %
- Luxembourg 1.0 %
- Germany 0.9 %
- Netherlands 0.6 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 45 | 11.2B SEK | 70.03 % |
| 2 | United Kingdom | 3 | 1.4B SEK | 8.85 % |
| 3 | Denmark | 3 | 628.6M SEK | 3.95 % |
| 4 | Belgium | 2 | 554.2M SEK | 3.48 % |
| 5 | Israel | 1 | 490.8M SEK | 3.08 % |
| 6 | Switzerland | 2 | 488.1M SEK | 3.06 % |
| 7 | Japan | 2 | 464.4M SEK | 2.91 % |
| 8 | Sweden | 3 | 333.3M SEK | 2.09 % |
| 9 | Luxembourg | 1 | 161.3M SEK | 1.01 % |
| 10 | Germany | 1 | 144M SEK | 0.90 % |
| 11 | Netherlands | 2 | 101.2M SEK | 0.64 % |
Cite this page
Titelia. "Holdings of SEB Läkemedelsfond". https://titelia.com/en/funds/SE56058